<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="rating_data"><item key="avg_stars">0</item><item key="total">0</item><item key="avg">0</item></item><item key="name">NK Cell Differentiation</item><item key="created">2023-08-02 09:36:08</item><item key="url">http://www.creative-bioarray.com/services/t-cell-nk-cell-differentiation.htm</item><item key="lastmodified">2023-08-02 09:36:08</item><item key="usage_data"><item key="layouts">0.0</item><item key="users">0</item></item><item key="popularity">0.0</item><item key="owner"><item key="username">creativebioarray</item><item key="url">/profile/21217/creativebioarray</item><item key="name">Hannah Cole</item></item><item key="species"><item>human</item><item>mouse</item><item>rat</item><item>fruitfly</item><item>nematode</item><item>zebrafish</item><item>thale-cress</item><item>frog</item><item>pig</item></item><item key="shortUrl">www.creative-bioarray.com</item><item key="id">1297</item><item key="short_description"> The revolutionary iPSC technology may provide a reliable and standardizable starting material to generate various immune cells for...</item><item key="role_permission"><item>biogpsusers</item></item><item key="permission_style">public</item><item key="type">iframe</item><item key="options">None</item><item key="tags"><item>cell</item><item>differentiation</item><item>nk</item></item><item key="description"> The revolutionary iPSC technology may provide a reliable and standardizable starting material to generate various immune cells for therapeutic purposes, to screen drugs and for disease modeling; and thus, overcome the difficulties of sourcing patient's primary cells, genome engineering these notoriously difficult-to-engineer cells, and avoid the variance in cellular characteristics associated with current methods.</item></data></biogps>
